Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT01123005
Imaging and Biomarkers of Hypoxia in Solid Tumors
Professor of Radiation Oncology (Radiation Therapy)
Professor of Medicine (Oncology)
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor, by courtesy, of Dermatology
Professor of Cardiothoracic Surgery
Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Anesthesiology, Perioperative & Pain Medicine
INCLUSION CRITERIA
- Any solid tumor malignancies of any stage meeting all of the following criteria:
Minimum tumor dimension is at least 1 cm (to ensure it is above the detection
threshold of PET imaging). Examples include but are not limited to: locally advanced
squamous cell carcinoma of the head and neck to be treated by either initial surgery
or primary chemoradiotherapy; inoperable non-small cell lung cancer or pancreatic
carcinoma to be treated with stereotactic radiotherapy, which may be biopsied again at
the time of percutaneous needle delivery of implanted fiducial markers.
- Patients with newly diagnosed malignancies should not have initiated treatment for
their disease before participating in this study. Patients with recurrent or second
malignancies may have had prior therapy as appropriate for their disease, but should
have completed all prior treatment at least 30 days before participation in this study
and should not have initiated new treatment for the current problem.
- Greater than or equal to eighteen years of age.
- Sufficiently healthy to tolerate all study procedures.
- Organ and marrow function sufficient to undergo planned therapy.
- Ability to understand and the willingness to sign a written informed consent document.
EXCLUSION CRITERIA
• Pregnant or nursing
drug: EF5
drug: Carbogen
procedure: PET Scan
drug: Dichloroacetate
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
CCTO
650-498-7061